What belongs together grows together – The merger of Nigu Chemie GmbH into AlzChem Trostberg GmbH
What belongs together grows together
Trostberg. Nigu Chemie GmbH in Waldkraiburg has been merged with its parent company AlzChem Trostberg GmbH with effect from July 1, 2021. The agreements already concluded in this regard are expected to be entered in the commercial registers of the companies involved in the second half of July.
Nigu Chemie GmbH’s business will be continued by AlzChem Trostberg GmbH, as will the “Nigu” brand, which is well established in professional circles. Nevertheless, the merger will significantly reduce the amount of bureaucracy within the AlzChem Group and bring further financial benefits. In the new organizational set-up, AlzChem will be able to act even better in the future as “one” company that is as flexible as it is powerful. Irrespective of this, the company is constantly working on becoming an even better partner for its customers and suppliers, with business processes that are as simple as possible, but nevertheless efficient.
AlzChem is a globally active specialty chemicals company that is one of the market leaders in its fields of activity, also in the international segment. With its broad product range, AlzChem benefits in a special way from the four very different global megatrends of energy efficiency, sustainability, healthy aging and population growth, insofar as efficiency in food production can be decisively improved. Here, AlzChem products offer attractive solutions in a wide range of different applications.
The company sees interesting growth prospects for itself in particular in the areas of human and animal nutrition, pharmaceuticals, agriculture, fine chemicals, metallurgy and renewable energies. The company’s broad product range includes dietary supplements, plant growth regulators and precursors for corona tests.
AlzChem employs around 1,630 people at four production sites in Germany and Sweden, and at two sales companies in the USA and China. In 2020, AlzChem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.